From harm reduction to drug user abstinence: A journey in drug treatment policy

Journal of Substance Use

Volumn 16, Issue 3, 2011, Pages 179-194

  McKeganey, Neil ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; OPIATE;

ARTICLE; CLINICAL RESEARCH; DRUG FATALITY; DRUG WITHDRAWAL; FUNDING; GOVERNMENT REGULATION; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MASS MEDIUM; OPIATE ADDICTION; PRIORITY JOURNAL; RISK REDUCTION; SOCIAL JUSTICE; SUBSTITUTION THERAPY; UNITED KINGDOM;

EID: 79955694876     PISSN: 14659891     EISSN: 14759942     Source Type: Journal    
DOI: 10.3109/14659891.2011.580228     Document Type: Article

References (38)

1. Advisory Council on the Misuse of Drugs. (1988). AIDS and drug misuse: Part 1. London: HMSO.
2. Ashton, M. (2008). The new abstentionists. London: Drugscope Publications.
3. BBC. (2005). Goldie lambasts methadone system. http://news.bbc.co.uk/1/ hi/scotland/4432912.stm
4. BBC (2007, October). Drug "rewards" given to addicts. http://news.bbc.co.uk/1/hi/uk/7049934.stm
5. BBC. (2008). Drug treatment - success or failure? http://www.bbc.co.uk/ blogs/thereporters/markeaston/2008/10/drug-treatment-officials-were.html
6. Canadian Centre on Substance Abuse. (1996). Harm reduction: Concepts and practice: A policy discussion paper, Canadian Centre on Substance Abuse (CCSA), National Working Group on Policy.
7. Department of Health. (2010). Updated guidance for prison based opioid maintenance prescribing.
8. Drugscope. (2009). Drug treatment at the crossroads what's it for, where its at and how to make it even better. Drug-scope Publications.
9. Dupont, R. (2000). The selfish brain learning from addiction. Minnesota: Hazelden Publishing.
10. Goldie, A. (2005). Goldie lambasts methadone programme. http://news.bbc.co.uk/1/hi/scotland/4432912.stm
11. Home Office. (2002). Updated drug strategy drug strategy directorate.
12. Home Office. (2010). 2010 drug strategy consultation paper.
13. Hunt, N. (2004). Public health or human rights: What comes first? The International Journal of Drug Policy, 15, 231-237. (Pubitemid 39094781)
14. Hunt, N. (2005, January). Public health or human rights? Author's rejoinder to responses. The International Journal of Drug Policy, 16(1), 5-7.
15. International Harm Reduction Association. (2009). What is harm reduction?
16. Levine, Harry G. (2001, October). The secret of world-wide drug prohibition: The varieties and uses of drug prohibition. http://www.hereinstead. com/sys-tmpl/worldwide/.
17. McDermott, P. (2010). Use your head druglink, pp. 26-27.
18. McIntosh, J., & McKeganey, N. (2001). Beating the dragon: The recovery from dependent drug use. Pearson Education.
19. McKeganey, N. (2009, January 12). System error. Drink and Drug News.
20. McKeganey, N. (2010) Controversies in Drugs Policy and Practice. Palgrave Macmillan.
21. McKeganey, N., Morris, Z., Neale, J., & Robertson, M. (2004). What are drug users looking for when the contact drug services abstinence or harm reduction. Drugs: Education Prevention and Policy, 11(5), 423-435. (Pubitemid 39508362)
22. McKeganey, N. P., Bloor, M., Robertson, M., Neale, J., & MacDougall, J. (2006). Abstinence and drug abuse treatment: Results from the drug outcome research in Scotland study. Drugs: Education, Prevention & Policy, 13(6).
23. Mee-Lee, D., Shulman, G. D., Fishman, M. et al., (Eds.) (2001). ASAM patient placement criteria for the treatment of substance-related disorders (2nd ed. Rev.) (ASAM PPC-2R). Chevy Chase, MD: American Society of Addiction Medicine.
24. Moskalewicz, J., Barrett, D., Bujalski, M., Da̧browska, K., Klingemann, H., Klingemann, J., Malczewski, A., & Struzik, M. (2007). Harm reduction coming of age: A summary of the 18th International Conference on the Reduction of Drug Related Harm-Warsaw, Poland: 13-17 May 2007, International Journal of Drug Policy, 18(6), 503-508. (Pubitemid 350180399)
25. National Institute for Health and Clinical Excellence. (2007). Psychosocial interventions and opioid detoxification National Institute for Health and Clinical Excellence.
26. National Treatment Agency. (2008). Annual report 2007-2008.
27. National Treatment Agency. (2010). Business plan for 2010-2011.
28. Newman, R. (2004). Comment on 'What are drug users looking for when they contact drug services: Abstinence or harm reduction?'. Drugs: Education, Prevention, and Policy. 12(4), 265-266.
29. Primarolo, D. (2008). National conference on injecting drug use.
30. Reinarman, C. (2004). Public health and human rights: The virtues of ambiguity. International Journal of Drug Policy, 15, 239-241. (Pubitemid 39094782)
31. Scottish Government. (2008). The road to recovery: A new approach to tackling Scotland's drug problem. Edinburgh.
32. Scottish Government. (2007). Review of methadone in drug treatment: Prescribing information and practice.
33. Stimson, G. (1990). AIDS and HIV challenge for British drug policy. British Journal of Addiction, 85, 329-339. (Pubitemid 20111256)
34. Stimson, G. (2007). Harm reduction coming of age: A local movement with global impact. International Journal of Drug Policy, 18, 67-69. (Pubitemid 46413743)
35. Stimson, G. V. (1995). AIDS and injecting drug use in the United Kingdom, 1988-1993: The policy response and the prevention of the epidemic. Social Science and Medicine, 41(5), 699-716.
36. Stimson, G. V., Alldritt, L., Dolan, K., Donoghoe, M., & Lart, R. A. (1988). Injecting equipment exchange schemes: Final report, The pilot syringe-exchange project in England and Scotland: A summary of the evaluation University of London, Goldsmiths' College. Addiction, 84(11), 1283-1284. Syringe Exchange Schemes: A report and some commentaries.
37. Strang, J., Hall, W., Hickman, M., & Bird, S. (2010). Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): Analyses using OD4 index for England and Scotland. British Medical Journal, 341, 4851.
38. Wodak, A., & Cooney, A. (2005). Effectiveness of sterile needle and syringe programmes. International Journal of Drug Policy, 165, s31-s44. (Pubitemid 41735173)